Recovery & Repair
BPC-157
A synthetic pentadecapeptide widely discussed within recovery protocols for soft tissue and gastrointestinal support.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- 10mg vial — reconstituted injectable$280
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is BPC-157?
BPC-157 is a synthetic peptide derived from a sequence found in human gastric juice. It has been studied primarily in preclinical models for its potential role in tissue repair and gastrointestinal integrity, and is prescribed under physician review as a compounded medication.
Mechanism
How it works
Researchers have investigated BPC-157 for its potential to influence angiogenesis — the formation of new blood vessels — and to modulate growth factor signaling involved in tissue regeneration. It is explored within wellness-focused protocols for its possible contribution to cellular repair pathways.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Potential support for tendon, ligament, and soft tissue recovery
- Explored within protocols addressing gut lining integrity
- Commonly discussed for joint comfort and mobility
- Used alongside structured rehabilitation and training programs
Administration
Format & dosing
Most patients are prescribed a daily subcutaneous injection from a reconstituted vial; a nasal spray format is available for patients who prefer a needle-free option. Your physician sets dosing, cycle length, and any rest periods.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for BPC-157 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Provider Determines Testing
Commonly reviewed at baseline
- CBC
- Comprehensive metabolic panel (CMP)
- hs-CRP
- Vitamin D
Follow-up & monitoring
Progress is generally tracked by symptom and function response rather than by a specific lab marker. Your physician sets any recheck interval.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
BPC-157 is not an FDA-approved drug product; it is compounded for an individual patient pursuant to a valid prescription. It is not appropriate for patients with active malignancy, and should be reviewed carefully alongside pregnancy, nursing, and existing medications.
Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Recovery & Repair
TB-500
Systemic tissue repair, flexibility, and injury recovery support.
Provider Determines Testing
Recovery & Repair
BPC-157 / TB-500
Dual-action recovery stack for tissue repair and systemic healing.
Provider Determines Testing
Recovery & Repair
BPC-157 / KPV / TB-500
Triple-action stack for repair, inflammation, and gut support.
Recent Labs Recommended
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.